Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4293027
Max Phase: Preclinical
Molecular Formula: C26H33N5O3S
Molecular Weight: 495.65
Molecule Type: Small molecule
Associated Items:
ID: ALA4293027
Max Phase: Preclinical
Molecular Formula: C26H33N5O3S
Molecular Weight: 495.65
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc2c(cc1OC)C(=O)N(CCCCN1C/C(=N\NC(=S)N(C)C)c3ccccc31)CC2
Standard InChI: InChI=1S/C26H33N5O3S/c1-29(2)26(35)28-27-21-17-31(22-10-6-5-9-19(21)22)13-8-7-12-30-14-11-18-15-23(33-3)24(34-4)16-20(18)25(30)32/h5-6,9-10,15-16H,7-8,11-14,17H2,1-4H3,(H,28,35)/b27-21+
Standard InChI Key: BYZLKBXRKFWFHW-SZXQPVLSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 495.65 | Molecular Weight (Monoisotopic): 495.2304 | AlogP: 3.14 | #Rotatable Bonds: 8 |
Polar Surface Area: 69.64 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.81 | CX Basic pKa: 3.12 | CX LogP: 3.17 | CX LogD: 3.17 |
Aromatic Rings: 2 | Heavy Atoms: 35 | QED Weighted: 0.34 | Np Likeness Score: -0.61 |
1. Pati ML, Niso M, Spitzer D, Berardi F, Contino M, Riganti C, Hawkins WG, Abate C.. (2018) Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ2) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors., 144 [PMID:29287249] [10.1016/j.ejmech.2017.12.024] |
Source(1):